ADAPY

Adaptimmune Therapeutics plc

USD

Set alert

Price alert · ADAPY

All alert types
0.02 USD 0.00 -11.54%
As of Oct 30, 2026
0.0205 Day range 0.0284
0.001 52-week range 0.07
YTD
-11.54%
1 year
-54.90%
Open
0.0284
Prev close
0.026
Mkt cap
6.10M
Vol
250.91K
Avg vol
190.14K
EPS
-0.59
P/E
0.00
More statistics
Low
0.0205
High
0.0284

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for ADAPY has not been loaded yet. Try again in a moment.

Period ending Jun 30, 2025 · select a line to chart its history

Revenue & Expenses

Revenue by
Other Income → Expenses: $560.00KProduct revenue, net → Revenue: $11.08MExpenses → Selling, General & Admin: $17.91MExpenses → Research & Development: $22.98MExpenses → Other Operating Expenses: $571.00KExpenses → Income Tax: $612.00KGross Profit → Expenses: $11.18MRevenue → Gross Profit: $11.18MRevenue → Cost of Revenue: $2.50MDevelopment revenue → Revenue: $2.60MNet Loss → Expenses: $30.34MOther Income$560.00KGross Profit$11.18MNet Loss$30.34MCost of Revenue$2.50MExpenses$42.08MSelling, General & Admin$17.91MResearch & Development$22.98MOther Operating Expenses$571.00KIncome Tax$612.00KRevenue$13.68MProduct revenue, net$11.08MDevelopment revenue$2.60M

Income statement

ADAPY quarterly income statement
13.68M
13.68M
2.50M
11.18M
41.46M
22.98M
18.48M
-30.29M
962.00K
612.00K
-30.34M
-30.34M
-30.34M
-30.34M
-0.12
-0.12
-0.12
-28.77M
-28.77M
1.58B
1.58B

Balance sheet

ADAPY quarterly balance sheet
27.78M
27.78M
9.31M
78.11M
46.90M
130.63M
4.51M
48.68M
51.51M
44.17M
201.59M
-1.17B
-10.61M
-70.96M
-70.96M
52.52M
48.68M
112.12M
3.81M
11.41M
150.08M
9.42M

Cash flow

ADAPY quarterly cash flow
2.51M
1.65M
-15.23M
-75.00K
1.65M
18.49M
18.51M
-34.78M
-590.00K
1.32M